Diurnal QT Analysis in Patients with Sotalol After Cardioversion of Atrial Fibrillation

Overview

Journal Ann Noninvasive Electrocardiol

Specialty Cardiology & Vascular Diseases

Date 2021 Feb 25

PMID 33629473

Citations 1

Authors

Hanna Lenhoff

Borje Darpo

Alex Page

Jean Philippe Couderc

Per Tornvall

Mats Frick

Affiliations

Soon will be listed here.

Abstract

Background: The risk of ventricular arrhythmias in patients on QT prolonging drugs is indicated to be increased early after cardioversion (CV) of atrial fibrillation (AF) to sinus rhythm (SR). Sotalol, used to prevent AF relapse, prolongs cardiac repolarization and corrected QT interval (QTc). A pronounced QTc prolongation is an established marker of pro-arrhythmias. Our objective was to use novel technique to quantify and evaluate the diurnal variation of the QTc interval after elective CV to SR in patients on sotalol or metoprolol.

Methods: Fifty patients underwent twelve-lead Holter recording for 24 hr after elective CV for persistent AF. All patients had the highest tolerable stable dose of sotalol (n = 27) or metoprolol (n = 23). Measurements of QT and RR intervals were performed on all valid beats.

Results: A clear diurnal variation of both HR and QTc was seen in both groups, more pronounced in patients on sotalol, where a high percentage of heartbeats with QTc >500 ms was observed, especially at night. Six patients (22%) on sotalol but none on metoprolol had >20% of all heart beats within the 24-hour recording with QTc >500 ms.

Conclusion: Twenty-four-hour Holter recordings with QT-measurement immediately after CV demonstrated that one in five patients on sotalol had >20% of all heart beats with prolonged QTc >500 ms, especially during night-time. The QTc diurnal variation was retained in patients on β-blockade or a potent class III anti-arrhythmic drug with β-blocking properties.

Citing Articles

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation.

Lenhoff H, Darpo B, Page A, Couderc J, Tornvall P, Frick M Ann Noninvasive Electrocardiol. 2021; 26(4):e12834.

PMID: 33629473 PMC: 8293609. DOI: 10.1111/anec.12834.

References

Bexton R, Vallin H, Camm A . Diurnal variation of the QT interval--influence of the autonomic nervous system. Br Heart J. 1986; 55(3):253-8. PMC: 1232162. DOI: 10.1136/hrt.55.3.253. View

Lenhoff H, Darpo B, Page A, Couderc J, Tornvall P, Frick M . Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation. Ann Noninvasive Electrocardiol. 2021; 26(4):e12834. PMC: 8293609. DOI: 10.1111/anec.12834. View

Weeke P, Delaney J, Mosley J, Wells Q, Van Driest S, Norris K . QT variability during initial exposure to sotalol: experience based on a large electronic medical record. Europace. 2013; 15(12):1791-7. PMC: 3888125. DOI: 10.1093/europace/eut153. View

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38):2893-2962. DOI: 10.1093/eurheartj/ehw210. View

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial.... Eur Heart J. 2021; 42(40):4194. DOI: 10.1093/eurheartj/ehab648. View

Vandael E, Vandenberk B, Vandenberghe J, Pince H, Willems R, Foulon V . Incidence of Torsade de Pointes in a tertiary hospital population. Int J Cardiol. 2017; 243:511-515. DOI: 10.1016/j.ijcard.2017.05.072. View

Tumuklu M, Tumuklu M, Nesterenko V, Jayathilake K, Beasley Jr C, Meltzer H . Twenty-Four-Hour Measures of Heart Rate-Corrected QT Interval, Peak-to-End of the T-Wave, and Peak-to-End of the T-Wave/Corrected QT Interval Ratio During Antipsychotic Treatment. J Clin Psychopharmacol. 2019; 39(2):100-107. DOI: 10.1097/JCP.0000000000001003. View

Ahmad K, Dorian P . Drug-induced QT prolongation and proarrhythmia: an inevitable link?. Europace. 2007; 9 Suppl 4:iv16-22. DOI: 10.1093/europace/eum167. View

De Vecchis R, Di Maio M, Noutsias M, Rigopoulos A, Ariano C, Di Biase G . High Prevalence of Proarrhythmic Events in Patients With History of Atrial Fibrillation Undergoing a Rhythm Control Strategy: A Retrospective Study. J Clin Med Res. 2019; 11(5):345-352. PMC: 6469886. DOI: 10.14740/jocmr3805. View

10.

Roden D . Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol. 1998; 21(5):1029-34. DOI: 10.1111/j.1540-8159.1998.tb00148.x. View

11.

Musat D, Adhaduk M, Preminger M, Arshad A, Sichrovsky T, Steinberg J . Correlation of QT interval correction methods during atrial fibrillation and sinus rhythm. Am J Cardiol. 2013; 112(9):1379-83. DOI: 10.1016/j.amjcard.2013.06.027. View

12.

Fetsch T, Bauer P, Engberding R, Koch H, Lukl J, Meinertz T . Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J. 2004; 25(16):1385-94. DOI: 10.1016/j.ehj.2004.04.015. View

13.

Furukawa Y, Shimizu H, Hiromoto K, Kanemori T, Masuyama T, Ohyanagi M . Circadian variation of beat-to-beat QT interval variability in patients with prior myocardial infarction and the effect of beta-blocker therapy. Pacing Clin Electrophysiol. 2006; 29(5):479-86. DOI: 10.1111/j.1540-8159.2006.00379.x. View

14.

Zhang Y, Post W, Blasco-Colmenares E, Dalal D, Tomaselli G, Guallar E . Electrocardiographic QT interval and mortality: a meta-analysis. Epidemiology. 2011; 22(5):660-70. PMC: 3150395. DOI: 10.1097/EDE.0b013e318225768b. View

15.

Vandersickel N, Kazbanov I, Defauw A, Pijnappels D, Panfilov A . Decreased repolarization reserve increases defibrillation threshold by favoring early afterdepolarizations in an in silico model of human ventricular tissue. Heart Rhythm. 2015; 12(5):1088-96. DOI: 10.1016/j.hrthm.2015.01.033. View

16.

Yamaguchi Y, Mizumaki K, Nishida K, Sakamoto T, Kataoka N, Nakatani Y . Time-Dependent Changes in QT Dynamics after Initiation and Termination of Paroxysmal Atrial Fibrillation. Pacing Clin Electrophysiol. 2015; 38(12):1418-24. DOI: 10.1111/pace.12746. View

17.

Lafuente-Lafuente C, Valembois L, Bergmann J, Belmin J . Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 2015; (3):CD005049. DOI: 10.1002/14651858.CD005049.pub4. View

18.

Niemeijer M, van den Berg M, Eijgelsheim M, van Herpen G, Stricker B, Kors J . Short-term QT variability markers for the prediction of ventricular arrhythmias and sudden cardiac death: a systematic review. Heart. 2014; 100(23):1831-6. DOI: 10.1136/heartjnl-2014-305671. View

19.

Cipriani A, Zorzi A, Ceccato D, Capone F, Parolin M, Donato F . Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. Int J Cardiol. 2020; 316:280-284. PMC: 7235573. DOI: 10.1016/j.ijcard.2020.05.036. View

20.

Darbar D, Kimbrough J, Jawaid A, McCray R, Ritchie M, Roden D . Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome. J Am Coll Cardiol. 2008; 51(8):836-42. PMC: 2271078. DOI: 10.1016/j.jacc.2007.09.066. View